Marian Hajduch Selected Research

bohemine

2/2011	Cancer drug-resistance and a look at specific proteins: Rho GDP-dissociation inhibitor 2, Y-box binding protein 1, and HSP70/90 organizing protein in proteomics clinical application.
8/2005	Protein fingerprints of anti-cancer effects of cyclin-dependent kinase inhibition: identification of candidate biomarkers using 2-D liquid phase separation coupled to mass spectrometry.
8/2002	Application of proteomics in the search for novel proteins associated with the anti-cancer effect of the synthetic cyclin-dependent kinases inhibitor, bohemine.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Marian Hajduch Research Topics

Disease

45	Neoplasms (Cancer) 05/2022 - 08/2002
10	Breast Neoplasms (Breast Cancer) 10/2018 - 09/2002
9	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 01/2018 - 04/2004
6	Glioblastoma (Glioblastoma Multiforme) 05/2022 - 08/2011
4	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 03/2020 - 11/2006
4	Cystic Fibrosis (Mucoviscidosis) 01/2020 - 01/2008
4	Colorectal Neoplasms (Colorectal Cancer) 01/2017 - 09/2012
3	Melanoma (Melanoma, Malignant) 03/2022 - 09/2016
3	Meningioma (Meningiomas) 01/2022 - 03/2013
3	Inflammation (Inflammations) 10/2021 - 12/2014
3	Asthma (Bronchial Asthma) 01/2020 - 05/2009
3	Infections 10/2018 - 01/2008
3	Adenocarcinoma 06/2016 - 04/2015
3	Carcinogenesis 06/2016 - 03/2007
2	Brain Neoplasms (Brain Tumor) 05/2022 - 12/2014
2	COVID-19 01/2022 - 06/2021
2	Bacterial Infections (Bacterial Infection) 01/2021 - 01/2020
2	Respiratory Hypersensitivity 01/2020 - 12/2014
2	Diamond-Blackfan Anemia (Anemia, Diamond Blackfan) 01/2020 - 07/2014
2	Alcoholism (Alcohol Abuse) 10/2019 - 12/2017
2	Triple Negative Breast Neoplasms 10/2018 - 06/2015
2	Amyloidosis 08/2018 - 04/2018
2	Esophageal Neoplasms (Esophageal Cancer) 06/2016 - 04/2015
2	Squamous Cell Carcinoma (Epidermoid Carcinoma) 06/2016 - 04/2015
2	Lung Neoplasms (Lung Cancer) 06/2014 - 11/2006
2	Mycoses (Diseases, Fungus) 06/2010 - 05/2006
2	Carcinoma (Carcinomatosis) 11/2008 - 08/2002
1	Hepatocellular Carcinoma (Hepatoma) 03/2022
1	Alzheimer Disease (Alzheimer's Disease) 02/2022
1	Lung Diseases (Lung Disease) 01/2022
1	Fatigue 01/2022
1	Hypoxia (Hypoxemia) 10/2021
1	Anemia 10/2021
1	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 10/2021
1	Iron-Deficiency Anemia (Anemia, Iron Deficiency) 10/2021
1	Papillomavirus Infections 01/2021

Drug/Important Bio-Agent (IBA)

15	Pharmaceutical PreparationsIBA 03/2022 - 01/2008
15	Biomarkers (Surrogate Marker)IBA 01/2022 - 08/2005
9	Proteins (Proteins, Gene)FDA Link 08/2018 - 08/2002
6	DNA (Deoxyribonucleic Acid)IBA 03/2022 - 03/2013
6	Biological ProductsIBA 01/2022 - 01/2008
6	MicroRNAs (MicroRNA)IBA 10/2020 - 08/2011
5	RNA (Ribonucleic Acid)IBA 03/2022 - 03/2013
5	FenretinideIBA 01/2020 - 01/2008
5	CeramidesIBA 01/2020 - 01/2008
4	CopperIBA 03/2022 - 12/2017
4	Phosphotransferases (Kinase)IBA 02/2022 - 06/2008
4	AcidsIBA 01/2018 - 06/2012
4	AnthracyclinesIBA 06/2015 - 03/2009
3	Ditiocarb (Sodium Diethyldithiocarbamate)FDA Link 03/2022 - 12/2017
3	Disulfiram (Antabuse)FDA Link 01/2022 - 12/2017
3	HepcidinsIBA 10/2021 - 07/2014
3	IronIBA 10/2021 - 06/2016
3	SiderophoresIBA 01/2021 - 01/2018
3	Estrogens (Estrogen)FDA Link 10/2018 - 09/2002
3	Docosahexaenoic AcidsIBA 03/2015 - 07/2009
3	Arachidonic Acid (Vitamin F)IBA 03/2015 - 07/2009
3	Aurora KinasesIBA 01/2013 - 06/2008
3	Daunorubicin (Cerubidine)FDA LinkGeneric 11/2012 - 04/2004
3	bohemineIBA 02/2011 - 08/2002
2	Formaldehyde (Formol)FDA Link 01/2022 - 09/2008
2	Long Noncoding RNAIBA 01/2022 - 03/2013
2	Messenger RNA (mRNA)IBA 01/2022 - 01/2020
2	ParaffinIBA 01/2022 - 09/2008
2	Fatty Acids (Saturated Fatty Acids)IBA 01/2020 - 07/2009
2	Immunoglobulin E (IgE)IBA 01/2020 - 12/2014
2	Peptides (Polypeptides)IBA 11/2019 - 06/2010
2	Epidermal Growth Factor (EGF)IBA 10/2018 - 01/2012
2	Progesterone FDA LinkGeneric 10/2018 - 03/2009
2	TriterpenesIBA 04/2018 - 01/2017
2	EstersIBA 11/2017 - 04/2007
2	Antineoplastic Agents (Antineoplastics)IBA 06/2016 - 09/2002
2	MethyltransferasesIBA 06/2016 - 12/2011
2	Prednisolone (Predate)FDA LinkGeneric 09/2014 - 04/2004
2	ProteomeIBA 11/2012 - 02/2011
2	Trastuzumab (Herceptin)FDA Link 10/2012 - 12/2010
2	ErbB Receptors (EGF Receptor)IBA 09/2012 - 11/2008
2	Capecitabine (Xeloda)FDA Link 01/2012 - 12/2010
2	Lapatinib (GW572016)FDA Link 01/2012 - 12/2010
2	Vincristine (Oncovin)FDA LinkGeneric 02/2011 - 04/2004
2	Cyclin-Dependent Kinases (cdk Proteins)IBA 08/2005 - 08/2002
1	MetalsIBA 03/2022
1	Purinergic P1 Receptors (Adenosine Receptor)IBA 03/2022
1	tau Proteins (tau Protein)IBA 02/2022
1	Anti-Bacterial Agents (Antibiotics)IBA 01/2022
1	MetallothioneinIBA 01/2022
1	Heavy MetalsIBA 01/2022
1	LipidsIBA 01/2022
1	CannabidiolIBA 01/2022
1	Bronchodilator Agents (Bronchodilators)IBA 01/2022
1	Expectorants (Mucolytics)IBA 01/2022
1	VaccinesIBA 01/2021
1	Deferoxamine (Desferal)FDA LinkGeneric 01/2021
1	Durapatite (Hydroxylapatite)IBA 08/2020

Therapy/Procedure

19	Therapeutics 05/2022 - 06/2008
5	Drug Therapy (Chemotherapy) 01/2022 - 03/2009
3	Neoadjuvant Therapy 10/2018 - 12/2008
2	Chemoradiotherapy 05/2022 - 11/2008
2	Radiotherapy 01/2020 - 04/2015
2	Adjuvant Chemotherapy 06/2015 - 12/2008